No abstract available
MeSH terms
-
Anticoagulants / economics
-
Anticoagulants / therapeutic use*
-
Atrial Fibrillation / complications
-
Azetidines / economics
-
Azetidines / therapeutic use*
-
Benzylamines / economics
-
Benzylamines / therapeutic use*
-
Cost-Benefit Analysis
-
Drug Costs
-
Humans
-
Safety
-
Thrombin / antagonists & inhibitors*
-
Thromboembolism / prevention & control
-
Warfarin / economics
-
Warfarin / therapeutic use
Substances
-
Anticoagulants
-
Azetidines
-
Benzylamines
-
melagatran
-
ximelagatran
-
Warfarin
-
Thrombin